SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Unquoted Biotechs

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates2/1/2012 1:46:50 PM
   of 253
 
IP Group plc – Portfolio company Oxford Nanopore to commercialise technology in 201201 Feb 2012IP Group plc – Portfolio company Oxford Nanopore to present DNA 'strand sequencing' technology at AGBT conference. Oxford Nanopore intends to commercialise independently in 2012

IP Group plc (LSE: IPO) (“IP Group” or “the Company” or “the Group”), the developer of intellectual property based businesses, is pleased to note that Oxford Nanopore Technologies Ltd ("Oxford Nanopore"), a spin-out company from the University of Oxford, has today announced it intends to commercialise DNA strand sequencing products directly to customers within 2012.

IP Group has a 21.5% beneficial stake in Oxford Nanopore, which is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores.

The full text of the Oxford Nanopore announcement follows:

“Oxford Nanopore to present DNA 'strand sequencing' technology at AGBT conference
-Company intends to commercialise independently in 2012-

1 February 2012, Oxford, UK. Oxford Nanopore Technologies Ltd. announces that Clive G Brown, Chief Technology Officer, will present at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida, on 17th February 2012 at 11.40am (EST) / 4.40pm (GMT). The talk is titled: “Single Molecule ‘Strand’ Sequencing Using Protein Nanopores and Scalable Electronic Devices”.

Oxford Nanopore intends to commercialise DNA strand sequencing products, directly to customers within 2012. At the AGBT presentation, Oxford Nanopore will show DNA strand sequencing data and other disruptive features of the Company's proprietary electronics-based sensing devices.

Further information will be provided at the time of the Company's presentation at the AGBT conference.”

For more information, please contact:

IP Group plc www.ipgroupplc.comAlan Aubrey, Chief Executive Officer+44 (0) 20 7444 0050Liz Vaughan-Adams, Communications+44 (0) 20 7444 0062 / +44 (0) 7979 853 802
liz.vadams@ipgroupplc.comFTI Consulting Ben Atwell, John Dineen+44 (0) 20 7831 3113 Oxford Nanopore Technologies Ltd www.nanoporetech.comZoe McDougall, Communications+44 (0) 845 034 7900 x2013 media@nanoporetech.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext